News

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss ...
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
Researchers say findings indicate the drugs offer neuroprotective benefits beyond glucose control and weight loss. Experts say it’s a link that needs further study. Doctors have found a way to ...
On a special episode (first released on July 16, 2025) of The Excerpt podcast: Despite the banning of hashtags that promote unhealthy weight loss content, the influence of SkinnyTok and thinspo ...
A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...
Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
WEIGHT loss jabs are changing people’s lives. For the 1.5 million Brits already on them, many are likely to be shedding the pounds, and fast. While new studies suggest they may make people ...
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new study.
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.